Predict your next investment

Asset/Investment Management

See what CB Insights has to offer

Investments

17

Portfolio Exits

4

About Xmark Opportunity Partners

Xmark Opportunity Partners is a Connecticut based privately owned investment firm that focuses on the life sciences sector.

Xmark Opportunity Partners Headquarter Location

90 Grove Street Suite 201

Ridgefield, Connecticut, 06877,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Xmark Opportunity Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Xmark Opportunity Partners in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Xmark Opportunity Partners Investments

17 Investments

Xmark Opportunity Partners has made 17 investments. Their latest investment was in Aeolus Pharmaceuticals as part of their Debt on August 8, 2010.

CBI Logo

Xmark Opportunity Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/19/2010

Debt

Aeolus Pharmaceuticals

$1M

Yes

4/4/2008

PIPE - II

Cellectar Biosciences

$5.68M

No

12/21/2007

PIPE

Advanced Life Sciences Holdings

$19.36M

No

8/13/2007

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

5/9/2007

PIPE

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/19/2010

4/4/2008

12/21/2007

8/13/2007

5/9/2007

Round

Debt

PIPE - II

PIPE

Unattributed VC

PIPE

Company

Aeolus Pharmaceuticals

Cellectar Biosciences

Advanced Life Sciences Holdings

Subscribe to see more

Subscribe to see more

Amount

$1M

$5.68M

$19.36M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

10

10

Xmark Opportunity Partners Portfolio Exits

4 Portfolio Exits

Xmark Opportunity Partners has 4 portfolio exits. Their latest portfolio exit was Avanir Pharmaceuticals on December 02, 2014.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/2/2014

Acq - P2P

$991

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

12/2/2014

00/00/0000

00/00/0000

00/00/0000

Exit

Acq - P2P

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.